SciELO - Scientific Electronic Library Online

 
vol.45 número1Farmacología del desarrollo de analgésicos opioides y no esteroideos en neonatos e infantesPreguntas y respuestas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Colombian Journal of Anestesiology

versión impresa ISSN 0120-3347

Rev. colomb. anestesiol. vol.45 no.1 Bogotá ene./jun. 2017

 

Letter to the Editor

Carta al Editor

Oscar L. Mosquera-Dussána, Daniel Botero-Rosasb,*, Henry Oliverosb

a Doctorado en Biociencias, Universidad de La Sabana, Chía-Cundinamarca, Colombia
b School of Medicine, Universidad de La Sabana, Chía-Cundinamarca, Colombia

Please cite this article as: Mosquera-Dussán OL, Botero-Rosas D, Oliveros H. Carta al Editor. Rev Colomb Anestesiol. 2017;45:80. 2256-2087.
* Corresponding author at: School of Medicine, La Sabana University, Chía-Cundinamarca, Colombia.
E-mail address: danybotero@hotmail.com (D. Botero-Rosas).


We are pleased to receive Dr. Eric B. Rosero's1 editorial comments regarding the trial: "Randomized cross-over clinical trial comparing two pharmacokinetic models of propofol using entropy indexes".2

One of the drawbacks of monitoring depth of anesthesia is that the records are usually contaminated with physiological and external artifacts; the reconstruction of a biological signal that accurately represents the relevant biological information is not an easy task. However, the Entropy module3 includes a pre-processing step that minimizes the introduction of noise into the signals recorded.

There are challenges inherent to the design of crossover trials but it is unlikely that the period effect occurred because the length of time of the surgical procedure was limited to maximum two hours. Given the type of procedure, during that time there were no volume exchanges or relevant changes in the physiological variables such as temperature and other hemodynamic conditions. It should be kept in mind that in terms of the carry-over effect, the washout period shall be enough to prevent the drug from having any pharmacodynamic effects and from interfering with the second treatment period.

With regards to the possibility of experiencing intraoperative recall upon the discontinuation of the propofol infusion (constant remifentanil infusion), no intraoperative awareness was reported during the patients' follow-up.

Funding comment

The authors did not receive any sponsorship to produce this article.

Conflicts of interest

The authors have no conflicts of interest to declare.


References

1. Rosero EB. La caracterización de la profundidad de la anestesia durante las infusiones controladas a objetivo: no es un trabajo fácil. Rev Colomb Anestesiol. 2016;4:187-9.         [ Links ]

2. Mosquera-Dussán O, Cárdenas A, Botero-Rosas D, Yepes A, Oliveros H, Henao R, et al. Ensayo clínico cruzado y aleatorizado para comparar 2 modelos farmacocinéticos de propofol usando índices de entropía. Rev Colomb Anestesiol. 2016;44:194-202.         [ Links ]

3. Viertiö-Oja H, Maja V, Särkelä M, Talja P, Tenkanen N, Tolvanen-Laakso H, et al. Description of the Entropy™ algorithm as applied in the Datex-Ohmeda S/5TM Entropy Module. Acta Anaesthesiol Scand. 2004;48:154-61.         [ Links ]

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons